Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9948)
All Articles published online
|
Publishing Process of This Article
|
Aug 7, 2019 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yu ZC, Cen YX, Wu BH, Wei C, Xiong F, Li DF, Liu TT, Luo MH, Guo LL, Li YX, Wang LS, Wang JY, Yao J. Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats. World J Gastroenterol 2019; 25(29): 3956-3971 [PMID: 31413530 DOI: 10.3748/wjg.v25.i29.3956] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i29/3956.htm |
| Number | Citing Articles |
| 1 |
Zhengwang Sun, Zirui He, Rujiao Liu, Zhe Zhang. Cation Lipid-Assisted PEG6-PLGA Polymer Nanoparticles Encapsulated Knocking Down Long ncRNAs Reverse Non-Coding RNA of Xist Through the Support Vector Machine Model to Regulate the Molecular Mechanisms of Gastric Cancer Cell Apoptosis. Journal of Biomedical Nanotechnology 2021; 17(7): 1305 doi: 10.1166/jbn.2021.3107
|
| 2 |
Zheng Yang, Mengni Bian, Junbing Ma, Yonghe Dong, Dan Yang, Min Qiu, Zhixiang Gao. Berberine regulates pulmonary inflammatory microenvironment and decreases collagen deposition in response to bleomycin‐induced pulmonary fibrosis in mice. Basic & Clinical Pharmacology & Toxicology 2023; 132(2): 154 doi: 10.1111/bcpt.13818
|
| 3 |
Adrienne M. Antonson, Morgan V. Evans, Jeffrey D. Galley, Helen J. Chen, Therese A. Rajasekera, Sydney M. Lammers, Vanessa L. Hale, Michael T. Bailey, Tamar L. Gur. Unique maternal immune and functional microbial profiles during prenatal stress. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-77265-x
|
| 4 |
Nazanin Momeni Roudsari, Naser-Aldin Lashgari, Saeideh Momtaz, Shaghayegh Abaft, Fatemeh Jamali, Pardis Safaiepour, Kiyana Narimisa, Gloria Jackson, Anusha Bishayee, Nima Rezaei, Amir Hossein Abdolghaffari, Anupam Bishayee. Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention. Pharmaceutics 2021; 13(8): 1195 doi: 10.3390/pharmaceutics13081195
|
| 5 |
Ursula Wade, Domingo A. Pascual-Figal, Fazale Rabbani, Marie Ernst, Adelin Albert, Isabelle Janssens, Yvan Dierckxsens, Somia Iqtadar, Nisar A. Khokhar, Ayesha Kanwal, Amjad Khan. The Possible Synergistic Pharmacological Effect of an Oral Berberine (BBR) and Curcumin (CUR) Complementary Therapy Alleviates Symptoms of Irritable Bowel Syndrome (IBS): Results from a Real-Life, Routine Clinical Practice Settings-Based Study. Nutrients 2024; 16(8): 1204 doi: 10.3390/nu16081204
|
| 6 |
Ewa Dudzińska, Andreas M. Grabrucker, Paweł Kwiatkowski, Robert Sitarz, Monika Sienkiewicz. The Importance of Visceral Hypersensitivity in Irritable Bowel Syndrome—Plant Metabolites in IBS Treatment. Pharmaceuticals 2023; 16(10): 1405 doi: 10.3390/ph16101405
|
| 7 |
Na Ri Choi, Min Ji Kwon, Woo-Gyun Choi, Sang Chan Kim, Jae-Woo Park, Joo Hyun Nam, Byung Joo Kim. The traditional herbal medicines mixture, Banhasasim-tang, relieves the symptoms of irritable bowel syndrome via modulation of TRPA1, NaV1.5 and NaV1.7 channels. Journal of Ethnopharmacology 2023; 312: 116499 doi: 10.1016/j.jep.2023.116499
|
| 8 |
Sicong Li, Xin Liu, Xiaoran Chen, Lei Bi. Research Progress on Anti-Inflammatory Effects and Mechanisms of Alkaloids from Chinese Medical Herbs. Evidence-Based Complementary and Alternative Medicine 2020; 2020: 1 doi: 10.1155/2020/1303524
|
| 9 |
Milad Ashrafizadeh, Masoud Najafi, Reza Mohammadinejad, Tahereh Farkhondeh, Saeed Samarghandian. Berberine Administration in Treatment of Colitis: A Review. Current Drug Targets 2020; 21(13): 1385 doi: 10.2174/1389450121666200621193758
|
| 10 |
Fang Cao, Weiyang Xia, Shengcheng Dai, Changkang Wang, Rui Shi, Yujie Yang, Cui Guo, Xue liang Xu, Jian Luo. Berberine: An inspiring resource for the treatment of colorectal diseases. Biomedicine & Pharmacotherapy 2023; 167: 115571 doi: 10.1016/j.biopha.2023.115571
|
| 11 |
Aiwen Feng, Shaosheng Su, Cheng Li, Yutian Kang, Jiasheng Qiu, Jun Zhou. Berberine decreases S100B generation to regulate gut vascular barrier permeability in mice with burn injury. Pharmaceutical Biology 2024; 62(1): 53 doi: 10.1080/13880209.2023.2291679
|
| 12 |
Diya Ye, Yuting Hu, Ning Zhu, Weizhong Gu, Gao Long, Enfu Tao, Marong Fang, Mizu Jiang, Mirella Giovarelli. Exploratory Investigation of Intestinal Structure and Function after Stroke in Mice. Mediators of Inflammation 2021; 2021: 1 doi: 10.1155/2021/1315797
|
| 13 |
Yulin Lu, Jingjing Huang, Yao Zhang, Zitong Huang, Weiming Yan, Tianran Zhou, Zhesheng Wang, Lu Liao, Hongying Cao, Bo Tan. Therapeutic Effects of Berberine Hydrochloride on Stress-Induced Diarrhea-Predominant Irritable Bowel Syndrome Rats by Inhibiting Neurotransmission in Colonic Smooth Muscle. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.596686
|
| 14 |
Hanjie He, Jieming Qin, Ziteng Ma, Wenkai Sun, Wende Yan, Gongxiu He, Maoxun Yang, Dangquan Zhang. Highly efficient regeneration and medicinal component determination of Phellodendron chinense Schneid. In Vitro Cellular & Developmental Biology - Plant 2020; 56(6): 775 doi: 10.1007/s11627-020-10080-1
|
| 15 |
İbrahim BAŞHAN. Effect of berberine on irritable bowel syndrome: A symptom-based review. International Journal of Plant Based Pharmaceuticals 2022; doi: 10.55484/ijpbp.1084455
|
| 16 |
Xinlu Li, Jianfeng Chen, Wennuo Feng, Chao Wang, Minyu Chen, Yifan Li, Jinghong Chen, Xinwei Liu, Qiong Liu, Jing Tian. Berberine ameliorates iron levels and ferroptosis in the brain of 3 × Tg-AD mice. Phytomedicine 2023; 118: 154962 doi: 10.1016/j.phymed.2023.154962
|
| 17 |
Yuejia Lan, Huan Wang, Jiasi Wu, Xianli Meng. Cytokine storm-calming property of the isoquinoline alkaloids in Coptis chinensis Franch. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.973587
|
| 18 |
Laura López-Gómez, Ana Bagüés, José Antonio Uranga, Raquel Abalo. A Comprehensive Overview of Irritable Bowel Syndrome. 2020; : 233 doi: 10.1016/B978-0-12-821324-7.00012-5
|
| 19 |
Yan Chen, Fuhao Chu, Jie Lin, Zeqi Su, Mengting Liao, Tao Li, Yuan Li, Nadia Johnson, Haocheng Zheng, Xia Ding. The mechanisms of action of WeiChang'An Pill (WCAP) treat diarrhoea-predominant irritable bowel syndrome (IBS-D) using network pharmacology approach and in vivo studies. Journal of Ethnopharmacology 2021; 275: 114119 doi: 10.1016/j.jep.2021.114119
|
| 20 |
Antonella Orlando, Guglielmina Chimienti, Maria Notarnicola, Francesco Russo. The Ketogenic Diet Improves Gut–Brain Axis in a Rat Model of Irritable Bowel Syndrome: Impact on 5-HT and BDNF Systems. International Journal of Molecular Sciences 2022; 23(3): 1098 doi: 10.3390/ijms23031098
|
| 21 |
Sihao Zhang, Danmei Tian, Zixuan Xia, Fengge Yang, Yanhui Chen, Zhihong Yao, Yi He, Xinglong Miao, Guirong Zhou, Xinsheng Yao, Jinshan Tang. Chang-Kang-Fang alleviates diarrhea predominant irritable bowel syndrome (IBS-D) through inhibiting TLR4/NF-κB/NLRP3 pathway. Journal of Ethnopharmacology 2024; : 118236 doi: 10.1016/j.jep.2024.118236
|
| 22 |
Cui Zhu, Meifang Le, Zhentao He, Yinshan Bai, Jun Yang, Jinling Ye, Zhuang Chen, Zongyong Jiang. Dietary berberine supplementation improves growth performance and alleviates gut injury in weaned piglets by modulating ileal microbiota and metabolites. Food & Function 2023; 14(9): 4143 doi: 10.1039/D3FO01044A
|
| 23 |
Ying Xiong, Hong Wei, Chong Chen, Lu Jiao, Juan Zhang, Yonggang Tan, Li Zeng. Coptisine attenuates post‑infectious IBS via Nrf2‑dependent inhibition of the NLPR3 inflammasome. Molecular Medicine Reports 2022; 26(6) doi: 10.3892/mmr.2022.12879
|
| 24 |
Mengnan Huang, Yuanyuan He, Lin Tian, Lu Yu, Qi Cheng, Zhu Li, Lina Gao, Shan Gao, Chunquan Yu. Gut microbiota-SCFAs-brain axis associated with the antidepressant activity of berberine in CUMS rats. Journal of Affective Disorders 2023; 325: 141 doi: 10.1016/j.jad.2022.12.166
|
| 25 |
Xin Gao, Tingting Xu, Yunlin Shi, Zhongzhong Bai, Jun Zhou, Hongli Wu, Fei Cao, Ping Wei. Production of fermentable sugar, ethanol, D-lactic acid, and biochar from starch-rich traditional Chinese medicine decoction residues. Biomass Conversion and Biorefinery 2023; doi: 10.1007/s13399-023-04997-x
|
| 26 |
Maite Casado-Bedmar, Åsa V. Keita. Potential neuro-immune therapeutic targets in irritable bowel syndrome. Therapeutic Advances in Gastroenterology 2020; 13: 175628482091063 doi: 10.1177/1756284820910630
|
| 27 |
Saeed Mohammadian Haftcheshmeh, Maliheh Abedi, Kazem Mashayekhi, Mohammad Javad Mousavi, Jamshid Gholizadeh Navashenaq, Asadollah Mohammadi, Amir Abbas Momtazi‐Borojeni. Berberine as a natural modulator of inflammatory signaling pathways in the immune system: Focus on NF‐κB, JAK/STAT, and MAPK signaling pathways. Phytotherapy Research 2022; 36(3): 1216 doi: 10.1002/ptr.7407
|
| 28 |
Xue Zhou, Meng Zeng, Fujiao Huang, Gang Qin, Zhangyong Song, Fangyan Liu. The potential role of plant secondary metabolites on antifungal and immunomodulatory effect. Applied Microbiology and Biotechnology 2023; 107(14): 4471 doi: 10.1007/s00253-023-12601-5
|